Clinical trial
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
NCT00171522 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171522 |
|---|---|
| Title | Preference of Tegaserod vs. PEG 3350 in Patients With Constipation |
| Official title | A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | Tegaserod and Polyethylene Glycol 3350 |
| Enrollment | 52 |
| Start date | May 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Mar 3, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: